GlassScriptPhysician profile
Charles Wojnarski
NPI 1194040030
$8,469.20
in general payments reported to CMS, 2019-2025
14 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,124 · 2020: $780 · 2021: $190 · 2022: $134 · 2023: $727 · 2024: $2,841 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,034 · Travel and Lodging: $1,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,034.37 |
| Travel and Lodging | $1,205.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,425.34 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| Bolton Medical INC | $1,486.55 | 2024-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Atricure, INC. | $1,247.03 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Abiomed | $1,123.81 | 2023-2025 | Impella |
| W. L. Gore & Associates, INC. | $384.29 | 2024-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Abbott Laboratories | $208.09 | 2021-2025 | Coroflow, Xience Skypoint, Perclose Prostyle |
| Artivion, INC. | $174.45 | 2019 | |
| Getinge USA Sales, LLC | $173.02 | 2022-2024 | Vasoview Hemopro 2 |
| Medtronic, INC. | $134.03 | 2021-2024 | Corevalve Evolut R |
| Haemonetics Corporation | $38.97 | 2025 | Teg6s Hemostasis System |
| Ethicon US, LLC | $20.53 | 2025 | Evarrest |
| Impactortho, INC. | $18.88 | 2025 | |
| Boston Scientific Corporation | $17.79 | 2024 | Watchman Flx |
| Zimmer Biomet Holdings, INC. | $16.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Wojnarski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.